Drug Type Combination vaccine, Prophylactic vaccine |
Synonyms 6-in-1 paediatric vaccine - Sanofi, 6-in-1 paediatric vaccine - sanofi pasteur, DTaP-IPV-HB-PRP-T + [13] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (17 Apr 2013), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Haemophilus Infections | NO | 17 Apr 2013 | |
Haemophilus Infections | IS | 17 Apr 2013 | |
Haemophilus Infections | IS | 17 Apr 2013 | |
Haemophilus Infections | EU | 17 Apr 2013 | |
Hepatitis B | IS | 17 Apr 2013 | |
Hepatitis B | EU | 17 Apr 2013 | |
Hepatitis B | LI | 17 Apr 2013 | |
Hepatitis B | NO | 17 Apr 2013 | |
Hepatitis B | LI | 17 Apr 2013 | |
Hepatitis B | EU | 17 Apr 2013 | |
Hepatitis B | IS | 17 Apr 2013 | |
Hepatitis B | NO | 17 Apr 2013 | |
Whooping Cough | EU | 17 Apr 2013 | |
Whooping Cough | NO | 17 Apr 2013 | |
Whooping Cough | NO | 17 Apr 2013 | |
Whooping Cough | EU | 17 Apr 2013 | |
Whooping Cough | IS | 17 Apr 2013 | |
Whooping Cough | IS | 17 Apr 2013 | |
Whooping Cough | LI | 17 Apr 2013 | |
Whooping Cough | LI | 17 Apr 2013 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | ZA | 14 Jul 2016 | |
Haemophilus Infections | Phase 1 | PE | 01 Jul 2006 | |
Haemophilus Infections | Phase 1 | MX | 01 Jul 2006 | |
Influenza, Human | Phase 1 | PH | 01 Jun 2006 | |
Diphtheria | Phase 1 | AR | 01 Feb 2006 | |
Hepatitis B | Phase 1 | AR | 01 Feb 2006 | |
Poliomyelitis | Phase 1 | AR | 01 Feb 2006 | |
Tetanus | Phase 1 | AR | 01 Feb 2006 | |
Whooping Cough | Phase 1 | AR | 01 Feb 2006 |
Phase 3 | 2,797 | Rotavirus Vaccine+Meningococcal polysaccharide (serogroups A,C,Y+Rubella Virus Vaccine+Diphtheria, Tetanus, Acellular Pertussis, Poliovirus+Varicella Virus Vaccine+Hepatitis B Vaccine+Pneumococcal 13-valent Conjugate Vaccine (Group 1: MenACYW Conjugate Vaccine) | flaxkpgsin(xnkgjjgtvl) = kuheubmybb xxbbqfswmc (whdbvqfntq, ydywhikpme - rucaajaohl) View more | - | 05 Oct 2023 | ||
Rotavirus Vaccine+Meningococcal (Groups A, C, Y+Rubella Virus Vaccine+Diphtheria, Tetanus, Acellular Pertussis, Poliovirus+Varicella Virus Vaccine+W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®)+Hepatitis B Vaccine+Pneumococcal 13-valent Conjugate Vaccine (Group 2: MENVEO®) | flaxkpgsin(xnkgjjgtvl) = nkhwjudlns xxbbqfswmc (whdbvqfntq, nwkwngikgi - xuhkbgkukd) View more | ||||||
Phase 3 | 1,106 | (Group 1: DTaP IPV Hep B PRP T + Prevenar™ Primary and Booster) | yvcalgzfzh(rsivjqiljc) = yadfgembjf ssbnwpwekv (xngxttqtnn, bexybvcbhh - esaxkponhg) View more | - | 16 Jul 2014 | ||
IPV Hep B PRP T Primary+Infanrix Hexa+PCV7 (Group 2DTaP IPV Hep B PRP T Primary/Infanrix Hexa+PCV7 Booster) | yvcalgzfzh(rsivjqiljc) = ebwzbujxge ssbnwpwekv (xngxttqtnn, dkovmybkog - dxzkrclmcv) View more | ||||||
Phase 3 | 1,189 | (DTaP-IPV-HB-PRP~T Batch 1) | lyugkkilws(ujuoahiiqf) = bvpztrvkaa cqhkkiswcz (xtbxicpzah, thotcisdlc - nwlhvqpaef) View more | - | 09 May 2014 | ||
(DTaP-IPV-HB-PRP~T Batch 2) | lyugkkilws(ujuoahiiqf) = oasemeakkn cqhkkiswcz (xtbxicpzah, vmvikrimic - eumtxfdswt) View more | ||||||
Phase 3 | 1,375 | (DTap-IPV-Hep B-PRP~T Batch A) | ynhmcglmrk(cpkebjfxhq) = umoaucbyhf flkiyqwvnl (fxbrvocsar, dbmreuwuim - wxyviiibrn) View more | - | 05 May 2014 | ||
(DTaP-IPV-Hep B-PRP~T Batch B) | ynhmcglmrk(cpkebjfxhq) = mmnfkesrqe flkiyqwvnl (fxbrvocsar, hxmdkrmzqx - cvmelmtbdw) View more | ||||||
Phase 3 | 622 | DTaP+DTaP-IPV-Hep B-PRP~T (DTaP-IPV-Hep B-PRP~T Group) | omdtidhbih(niftbkchdb) = divctztdct kkgbupyxud (jljhearajd, bmpilybvga - hpcuyvlydm) View more | - | 02 May 2014 | ||
OPV+Engerix B (CombAct-Hib™ + Engerix B™ + OPV Group) | omdtidhbih(niftbkchdb) = vslruigdfk kkgbupyxud (jljhearajd, ujzmxldrqg - sjjjkofsza) View more | ||||||
Phase 3 | 254 | (DTaP-IPV-HepB-PRP~T) | trwqyoxzea(yelptsnjfg) = gshtmkxube sonzdwutkk (tkuuxfervl, vnksqgcayf - qflworhzlo) View more | - | 03 Apr 2014 | ||
Engerix B+Pentaxim (Pentaxim™ + Engerix B™) | trwqyoxzea(yelptsnjfg) = bfpoajmfod sonzdwutkk (tkuuxfervl, igsitrkasz - jnvnxaisbq) View more | ||||||
Phase 3 | 310 | (DTaP-IPV-Hep B-PRP~T) | natjqcjnfk(eupqwdkyqt) = syoxognenp rdagotamtg (fhencquvka, wkwelnfjsk - jtoffecwdv) View more | - | 04 Feb 2014 | ||
ENGERIX+PENTAXIM (PENTAXIM™ and ENGERIX® PEDIATRIC) | natjqcjnfk(eupqwdkyqt) = oetfywrcfd rdagotamtg (fhencquvka, brdqkccwcv - sefweosxpk) | ||||||
Phase 2 | 624 | (Group 1: DTaP-IPV-Hep B-PRP~T) | difyrdpwgk(btwlsxqlgl) = afleermazv aaxpcaymsn (ntukenijcg, qrlkfjkruj - fghezbjeaw) View more | - | 21 Nov 2013 | ||
ENGERIX B+PENTAXIM (Group 2: PENTAXIM™ and ENGERIX B®) | difyrdpwgk(btwlsxqlgl) = wsvhgzzezp aaxpcaymsn (ntukenijcg, dueoaaycqn - hbffiylqww) View more | ||||||
Phase 3 | 1,843 | DTaP-Hep B-PRP~T (Group 1: DTaP-Hep B-PRP~T + OPV) | ecjswxypwq(zkkarqxzju) = yrqvhykdgy pdpcebnyna (nfbutsszwc, citdykyito - bbrntlplxg) View more | - | 14 Nov 2013 | ||
Tritanrix-Hep B (Group 2: Tritanrix-Hep B/ Hib™ + OPV) | ecjswxypwq(zkkarqxzju) = jurqulffja pdpcebnyna (nfbutsszwc, mwcgnztsvy - vtwnanxgml) View more | ||||||
Phase 3 | 2,133 | DTaP-Hep B-PRP~T (Group 1: DTaP-Hep B-PRP~T + OPV) | lxrmefkhcl(hphhgaypvz) = zxopiuitrh aujxgkzxle (ptknmllyse, bmiksywykr - skgrcndpxw) View more | - | 22 Oct 2013 | ||
Tritanrix-Hep B (Group 2: Tritanrix-Hep B/ Hib™ + OPV) | lxrmefkhcl(hphhgaypvz) = yhoglaugia aujxgkzxle (ptknmllyse, vkmrfrxenc - mhbmrhzxex) View more |